"CMC Vellore has presented the preliminary data which is under review. The working group will take it up in their meeting tomorrow [Wednesday]," a member of the group said, requesting not to be named. The data is also under review by the Central Drugs Standard Control Organisation.from Industry-Economic Times
Read The Rest:economictimes...
